| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e4d7b42b54ac04ad30d06ba26e5b021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c37762188a56acca3ecbc14acf8881b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_201f7a85b9be36e8ac674627a9abedb3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0474 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K103-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2010-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_602c637c67bad3d161d3ae62525e98b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be1dcddf5ab668b9fa0040fefca369be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_120257db9f78650b8a6c923a759c1b82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a50b72be878c34f510cba1853402fff |
| publicationDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2956325-B1 |
| titleOfInvention |
THERAPEUTIC DOSE RADIOMARKETING WITH RHENIUM-188 AND AUTOMATION THEREOF, IN PARTICULAR FOR THE TREATMENT OF LIVER CANCER |
| abstract |
Liver cancer in humans is the fifth most common cancer in the world. Chemoembolization is an alternative strategy to surgery and radiotherapy that is attractive due to the effectiveness thereof and the limitation of side-effects for the patient. Formulations according to prior art have problems of stability and effectiveness which limit the clinical use thereof. The present invention therefore relates to a composition for treating liver cancer in humans including a complex of the following formula (I): [M(RCS3)2(RCS2)] where M is 188Re with high activity, that is to say greater than 3.7 Gbq, and a lipophilic organic base emulsified with an aqueous phase, R is an alkyl, cycloalkyl or aryl group, unsubstituted or substituted with one or more substituents selected from among halogen atoms, a hydroxyl group, alkyl groups and alkoxy groups. |
| priorityDate |
2010-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |